CAGAS
PHAS
Capital Advisory Group Advisory Services’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,800
| Closed | -$4K | – | 516 |
|
|
2022
Q1 | $4K | Buy |
+2,800
| New | +$4K | ﹤0.01% | 455 |
|
|
2021
Q4 | – | Sell |
-2,800
| Closed | -$9K | – | 550 |
|
|
2021
Q3 | $9K | Hold |
2,800
| – | – | ﹤0.01% | 411 |
|
|
2021
Q2 | $10K | Hold |
2,800
| – | – | ﹤0.01% | 400 |
|
|
2021
Q1 | $10K | Hold |
2,800
| – | – | ﹤0.01% | 388 |
|
|
2020
Q4 | $9K | Hold |
2,800
| – | – | ﹤0.01% | 384 |
|
|
2020
Q3 | $10K | Hold |
2,800
| – | – | 0.01% | 321 |
|
|
2020
Q2 | $13K | Hold |
2,800
| – | – | 0.01% | 285 |
|
|
2020
Q1 | $9K | Buy |
+2,800
| New | +$9K | 0.01% | 248 |
|
|
2019
Q4 | – | Sell |
-2,800
| Closed | -$12K | – | 446 |
|
|
2019
Q3 | $12K | Hold |
2,800
| – | – | 0.01% | 266 |
|
|
2019
Q2 | $37K | Buy |
+2,800
| New | +$37K | 0.02% | 173 |
|